Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


House Commerce Cmte. Launches Inquiry Into FDA Single-Use, Reuse Regs

This article was originally published in The Gray Sheet

Executive Summary

House Commerce Committee members will decide whether to hold a hearing on FDA regulation of reprocessed single-use medical devices after they receive a response from FDA Commissioner Jane Henney to a Dec. 8 request for information.

You may also be interested in...

GAO Inquiry Into Device Reprocessing, FDA Oversight To Be Sought By Senate

The Senate Health, Education, Labor and Pensions Committee will ask the General Accounting Office to undertake a comprehensive evaluation of the practice of reprocessing devices, according to committee staffers.

HHS Inspector General Will Examine Orphan Indications For Top-Selling Drugs In Medicare

OIG will focus on successful drugs that have been repurposed as orphans, noting nine of the 10 top selling drugs have both orphan and non-orphan indications.

Basilea Stresses Derazantinib's FGFR Kinase Differentiation

Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts